Biodexa Pharmaceticals Stock Market Value
| BDRX Stock | 4.98 0.41 8.97% |
| Symbol | Biodexa |
Biodexa Pharmaceticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biodexa Pharmaceticals. If investors know Biodexa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biodexa Pharmaceticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (75.55) | Revenue Per Share 0.435 | Quarterly Revenue Growth (0.64) | Return On Assets (0.38) | Return On Equity (0.97) |
The market value of Biodexa Pharmaceticals is measured differently than its book value, which is the value of Biodexa that is recorded on the company's balance sheet. Investors also form their own opinion of Biodexa Pharmaceticals' value that differs from its market value or its book value, called intrinsic value, which is Biodexa Pharmaceticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biodexa Pharmaceticals' market value can be influenced by many factors that don't directly affect Biodexa Pharmaceticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biodexa Pharmaceticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biodexa Pharmaceticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biodexa Pharmaceticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biodexa Pharmaceticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biodexa Pharmaceticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biodexa Pharmaceticals.
| 07/05/2023 |
| 11/26/2024 |
If you would invest 0.00 in Biodexa Pharmaceticals on July 5, 2023 and sell it all today you would earn a total of 0.00 from holding Biodexa Pharmaceticals or generate 0.0% return on investment in Biodexa Pharmaceticals over 510 days. Biodexa Pharmaceticals is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Biodexa Pharmaceticals is entity of United States More
Biodexa Pharmaceticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biodexa Pharmaceticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biodexa Pharmaceticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 97.78 | |||
| Value At Risk | (17.24) | |||
| Potential Upside | 11.91 |
Biodexa Pharmaceticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biodexa Pharmaceticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biodexa Pharmaceticals' standard deviation. In reality, there are many statistical measures that can use Biodexa Pharmaceticals historical prices to predict the future Biodexa Pharmaceticals' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (1.51) | |||
| Total Risk Alpha | (2.95) | |||
| Treynor Ratio | (0.35) |
Biodexa Pharmaceticals Backtested Returns
Biodexa Pharmaceticals secures Sharpe Ratio (or Efficiency) of -0.0859, which signifies that the company had a -0.0859% return per unit of risk over the last 3 months. Biodexa Pharmaceticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biodexa Pharmaceticals' Mean Deviation of 6.68, risk adjusted performance of (0.06), and Standard Deviation of 11.76 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 3.23, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biodexa Pharmaceticals will likely underperform. At this point, Biodexa Pharmaceticals has a negative expected return of -1.03%. Please make sure to confirm Biodexa Pharmaceticals' jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Biodexa Pharmaceticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.85 |
Very good predictability
Biodexa Pharmaceticals has very good predictability. Overlapping area represents the amount of predictability between Biodexa Pharmaceticals time series from 5th of July 2023 to 16th of March 2024 and 16th of March 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biodexa Pharmaceticals price movement. The serial correlation of 0.85 indicates that around 85.0% of current Biodexa Pharmaceticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.85 | |
| Spearman Rank Test | 0.84 | |
| Residual Average | 0.0 | |
| Price Variance | 89.97 |
Biodexa Pharmaceticals lagged returns against current returns
Autocorrelation, which is Biodexa Pharmaceticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biodexa Pharmaceticals' stock expected returns. We can calculate the autocorrelation of Biodexa Pharmaceticals returns to help us make a trade decision. For example, suppose you find that Biodexa Pharmaceticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Biodexa Pharmaceticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biodexa Pharmaceticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biodexa Pharmaceticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biodexa Pharmaceticals stock over time.
Current vs Lagged Prices |
| Timeline |
Biodexa Pharmaceticals Lagged Returns
When evaluating Biodexa Pharmaceticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biodexa Pharmaceticals stock have on its future price. Biodexa Pharmaceticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biodexa Pharmaceticals autocorrelation shows the relationship between Biodexa Pharmaceticals stock current value and its past values and can show if there is a momentum factor associated with investing in Biodexa Pharmaceticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biodexa Stock Analysis
When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.